Sara L Delaney, MS, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2846 Brandt Dr S, Fargo, ND 58104 Phone: 701-232-2340 Fax: 701-232-2330 |
Erin Barr Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-6970 Fax: 701-234-7391 |
Arica Caitlin Strehlow, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3175 Sienna Dr S Ste 103, Fargo, ND 58104 Phone: 701-532-1906 |
Bailey Jean Fletcher, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 4500 36th Ave S Ste 200, Fargo, ND 58104 Phone: 701-532-1507 Fax: 701-532-1529 |
Jessica Marie Franke, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3439 19th St S, Fargo, ND 58104 Phone: 701-238-6241 |
Patricia Cummings, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1601 13th Ave S, Fargo, ND 58103 Phone: 701-466-1765 |
Allison Marie Nasset, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 |
Miranda Volk, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3060 Frontier Way S, Fargo, ND 58104 Phone: 701-232-2340 Fax: 701-232-2330 |
Lindsay Wickham, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-6862 |
James W Dulka, M.S., CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1411 32nd St S, Fargo, ND 58103 Phone: 701-532-1507 |
Whitney J Voss, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1702 University Dr S, Fargo, ND 58103 Phone: 701-364-8000 |
Katie B Bergh, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3003 32nd Ave S, Fargo, ND 58103 Phone: 701-232-2340 |
Erin Jore Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3001 11th St S, Fargo, ND 58103 Phone: 701-356-0062 Fax: 701-356-5412 |
Mrs. Brenda Joan Patzner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3003 32nd Ave S, Suite 9, Fargo, ND 58103 Phone: 701-232-2340 Fax: 701-232-2330 |
Amanda Lachance, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1720 University Dr S, Fargo, ND 58103 Phone: 701-417-4437 Fax: 701-417-4069 |
Mrs. Kimberly Joan Smith, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-5799 |
Mckenzie Lee Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1717 S University, Feeding Disorders 3rd Floor, Fargo, ND 58103 Phone: 701-417-5294 |
Nanette S Kennelly, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1220 Main Ave, Suite 100, Fargo, ND 58103 Phone: 701-364-5433 Fax: 701-364-2256 |
Mr. Jill Suzanne Suppes, MS-CCC/SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3001 University Dr S, Fargo, ND 58103 Phone: 701-356-0062 |
Alyce A. Wiemken, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2810 Parkview Cir S, Fargo, ND 58103 Phone: 701-298-9767 |
News Archive
Using just two anticlotting medicines for patients who have atrial fibrillation and have had a stent placed in a heart artery is safer than using the current standard treatment of three medications, according to a new study presented by Brigham and Women's Hospital cardiologist Christopher Cannon, MD, at the European Society of Cardiology and published simultaneously in The New England Journal of Medicine.
Take Care Health Systems is now offering nebulizer treatments, when clinically appropriate, for clinic patients exhibiting acute respiratory distress.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
A global team of investigators has identified a key protein involved in Hantavirus Pulmonary Syndrome, a serious and sometimes fatal respiratory disease, according to research published today in the journal Nature.
The natural world often provides the answer to unsolved medical problems. On this occasion, the solution to a challenge posed by cancer has come about from the immune system of camelids.
› Verified 4 days ago